What's Happening?
The United States is experiencing a significant resurgence of measles, leading to the loss of its measles elimination status in 2026, with over 5,000 cases reported nationwide. A Public Health Alerts report, based on data from January 1, 2025, to September
28, 2026, across 16 jurisdictions, details 112 confirmed measles cases in pregnant women. Of these, 108 (96%) were part of outbreaks involving 50 or more cases, and 110 (98%) of the infected women were unvaccinated or had unknown vaccination status. This surge has also resulted in 13 confirmed cases of congenital measles in infants, a condition previously rare in the U.S. healthcare system. Twenty-six pregnant women (23%) required hospitalization for reasons unrelated to labor, and 11 (10%) developed pneumonia. Among 19 live births to infected mothers, eight were preterm, and eight required neonatal intensive care. These findings highlight the severe impact of declining vaccination rates on maternal and neonatal health.
Why It's Important?
The re-emergence of congenital measles and the high number of cases among pregnant women underscore a critical public health crisis in the U.S. The country's loss of measles elimination status, achieved in 2000, signifies a weakening of community immunity, primarily due to declining MMR vaccination rates below the 95% threshold needed to prevent outbreaks. This situation places vulnerable populations, particularly pregnant women and infants, at severe risk. Measles during pregnancy can lead to serious complications for both mother and child, including pneumonia, preterm birth, and congenital measles in infants, which can result in severe neurological issues like meningoencephalitis. The increased burden on healthcare systems, with more hospitalizations and NICU admissions, also strains resources. The report emphasizes the urgent need for healthcare providers to be prepared for such cases, especially in communities with low vaccination coverage, and to recommend post-exposure prophylaxis for exposed pregnant women.
What's Next?
In response to the ongoing measles outbreaks, healthcare systems and clinicians are advised to enhance preparedness for managing measles in pregnant women and their infants, particularly in undervaccinated communities. The CDC recommends post-exposure prophylaxis with intravenous immunoglobulin for pregnant women exposed to measles who lack documented MMR vaccination or other immunity evidence. For neonates exposed in utero, immunoglobulin is recommended at birth to mitigate the morbidity associated with congenital measles. Public health efforts will likely intensify to promote MMR vaccination to restore community immunity and prevent further spread. Continued monitoring of vaccination rates and targeted interventions in areas with low coverage will be crucial. The medical community will also need to remain vigilant for potential long-term neurological complications in infants affected by congenital measles, such as subacute sclerosing panencephalitis.
Beyond the Headlines
The resurgence of measles and the subsequent impact on pregnant women and infants reveal deeper societal challenges related to vaccine hesitancy and public health communication. The decline in vaccination rates reflects a broader erosion of trust in public health institutions and scientific consensus, fueled by misinformation. This situation not only poses immediate health risks but also threatens the foundational principles of herd immunity, which protects those who cannot be vaccinated, such as infants and immunocompromised individuals. The ethical implications extend to the collective responsibility of maintaining public health through vaccination, balancing individual choice with community well-being. Long-term, this trend could lead to the re-establishment of other vaccine-preventable diseases, increasing healthcare costs and potentially reversing decades of public health progress. Addressing this requires a multi-faceted approach, including robust public health campaigns, improved vaccine access, and strategies to counter misinformation effectively.













